Managing emetic risk is crucial because nausea and vomiting can lead to severe dehydration, electrolyte imbalances, and malnutrition, which can further weaken a cancer patient. Uncontrolled emesis can also cause patients to delay or refuse further treatment, potentially compromising the efficacy of cancer therapy.
